JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma Multiforme (GBM)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Tiantan Hospital, Beijing, China
Contact: Study coordinator (Wenbin LI) · yahuisu@jenkem.com · 8610-82156767

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

Glioblastoma

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Boston, United States

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Glioblastoma · Gliosarcoma

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Miami, United States

A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme

Abroad (travel likely)RecruitingPHASE1

Seoul, South Korea

Vortioxetine for Newly Diagnosed Glioblastoma

Glioblastoma

Abroad (travel likely)RecruitingPHASE2

Zurich, Switzerland